ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Hui-Ming Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1162-1411; OpenAlex author ID A5114430024. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper

Papers 2

Hyperglycemia Promotes Pancreatic Cancer Initiation and Progression by Activating the Wnt/β-Catenin Signaling Pathway. Co-author DOI 10.2174/1871520621666210201095613 ↗
Three hypomethylated genes were associated with poor overall survival in pancreatic cancer patients. Co-author DOI 10.18632/aging.101785 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zheng Wang · 2 shared papers, 2019–2021 · strength 0.27
- Paper Hyperglycemia Promotes Pancreatic Cancer Initiation and Progression by Activating the Wnt/β-Catenin Signaling Pathway. DOI 10.2174/1871520621666210201095613 ↗
- Paper Three hypomethylated genes were associated with poor overall survival in pancreatic cancer patients. DOI 10.18632/aging.101785 ↗
Chang Liu · 2 shared papers, 2019–2021 · strength 0.27
- Paper Hyperglycemia Promotes Pancreatic Cancer Initiation and Progression by Activating the Wnt/β-Catenin Signaling Pathway. DOI 10.2174/1871520621666210201095613 ↗
- Paper Three hypomethylated genes were associated with poor overall survival in pancreatic cancer patients. DOI 10.18632/aging.101785 ↗
Xing Zhang · 1 shared paper, 2019 · strength 0.10
- Paper Three hypomethylated genes were associated with poor overall survival in pancreatic cancer patients. DOI 10.18632/aging.101785 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.